According to a retrospective cohort study by Elizabeth Spencer at Mount Sinai, #upadacitinib can be considered an effective maintenance treatment for pediatric patients with refractory #CrohnDisease.
#PediatricCrohnsDisease #PediatricIBD #IBDSky #GISky
www.docwirenews.com/post/real-wo...
docwirenews.com
Upadacitinib Maintenance for Pediatric CD | Gastro Today
Real-world data showed that upadacitinib is effective maintenance therapy for pediatric Crohn’s disease.
